In this video, Fool.com health care analysts David Williamson and Max Macaluso discuss Gilead, Amarin, and Cyclacel's intraday pops of more than 5%. One reported excellent earnings, another is subject to buyout rumors, and a third continues its recent winning streak. Watch and find out what this means for these stocks, their competitors, and investors.
